Edesa Biotech (EDSA) Shares Issued (2013 - 2026)
Edesa Biotech (EDSA) posted Shares Issued of $378039.0 for Q4 2025, little changed sequentially from $378039.0 in Q3 2025, and down 1.31% YoY from $383040.0 in Q4 2024.
Edesa Biotech (EDSA) Shares Issued (2013 - 2026) Analysis & Trends
Edesa Biotech has reported Shares Issued for 11 years, with the latest figure at $378039.0 in Q4 2025.
- Quarterly Shares Issued fell 1.31% year-over-year to $378039.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $378039.0 (down 1.31% YoY) and the FY2025 annual result came in at $378039.0, down 1.31% from the prior year.
- Shares Issued steadied at $378039.0 in Q4 2025 per EDSA's latest filing, from $378039.0 in the prior quarter.
- Over five years, Shares Issued peaked at $2.3 million in Q1 2022 and troughed at $378039.0 in Q3 2025.
- A 4-year average of $970893.8 and a median of $383040.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2021 and 2025: Shares Issued surged 341.32% in 2021, then slipped 1.31% in 2025.
- Over 4 years, Shares Issued stood at $1.8 million in 2021, then climbed by 24.5% to $2.2 million in 2022, then plunged by 82.64% to $383040.0 in 2024, then decreased by 1.31% to $378039.0 in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $378039.0, $378039.0, and $378235.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | 378,039.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 378,039.00 |
| Jun 30, 2026 | 378,039.00 |
| Dec 31, 2025 | 378,039.00 |
| Dec 31, 2025 | 378,039.00 |
| Sep 30, 2025 | 378,039.00 |
| Sep 30, 2025 | 378,039.00 |
| Jun 30, 2025 | 378,235.00 |
| Jun 30, 2025 | 378,235.00 |
| Mar 31, 2025 | 382,666.00 |
| Mar 31, 2025 | 382,666.00 |
| Dec 31, 2024 | 383,040.00 |
| Dec 31, 2024 | 383,040.00 |
| Sep 30, 2024 | 383,040.00 |
| Sep 30, 2024 | 383,040.00 |
| Jun 30, 2024 | 383,040.00 |
| Jun 30, 2024 | 383,040.00 |
| Dec 31, 2022 | 2.21 Mn |
| Dec 31, 2022 | 2.21 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Mar 31, 2022 | 2.26 Mn |